RET and colorectal carcinoma: Beyond lung cancer, RET fusions with a diversity of fusion partners (KIF5B, NCOA4, CCDC6, BCR, GOLGA5) have been identified in spitzoid neoplasms, chronic myelomonocytic leukemia and CRC [3].